US4880635B1
(en)
*
|
1984-08-08 |
1996-07-02 |
Liposome Company |
Dehydrated liposomes
|
GB8609537D0
(en)
*
|
1986-04-18 |
1986-05-21 |
Ici Plc |
Polyesters
|
DE3720806C2
(de)
*
|
1986-07-03 |
1997-08-21 |
Clariant Finance Bvi Ltd |
Verwendung eines Stabilisators in Peroxydbleichverfahren
|
US4758435A
(en)
*
|
1986-08-11 |
1988-07-19 |
American Cyanamid Company |
Estradiol implant composition and method for preparation
|
DE3641692A1
(de)
*
|
1986-12-06 |
1988-06-09 |
Boehringer Ingelheim Kg |
Katalysatorfreie resorbierbare homopolymere und copolymere
|
DE3710175A1
(de)
*
|
1987-02-12 |
1988-08-25 |
Hoechst Ag |
Mehrteilige implantierbare arzneizubereitung mit langzeitwirkung
|
AU634723B2
(en)
*
|
1988-08-08 |
1993-03-04 |
Biopak Technology, Ltd. |
Degradable thermoplastic from lactides
|
US5424346A
(en)
*
|
1988-08-08 |
1995-06-13 |
Ecopol, Llc |
Biodegradable replacement of crystal polystyrene
|
US5180765A
(en)
*
|
1988-08-08 |
1993-01-19 |
Biopak Technology, Ltd. |
Biodegradable packaging thermoplastics from lactides
|
WO1990001521A1
(en)
*
|
1988-08-08 |
1990-02-22 |
Battelle Memorial Institute |
Degradable thermoplastic from lactides
|
US6323307B1
(en)
|
1988-08-08 |
2001-11-27 |
Cargill Dow Polymers, Llc |
Degradation control of environmentally degradable disposable materials
|
US5250584A
(en)
*
|
1988-08-31 |
1993-10-05 |
G-C Dental Industrial Corp. |
Periodontium-regenerative materials
|
JP2714454B2
(ja)
*
|
1988-11-07 |
1998-02-16 |
三井東圧化学株式会社 |
生体吸収性ポリエステルの製造方法
|
US4990336A
(en)
*
|
1989-02-08 |
1991-02-05 |
Biosearch, Inc. |
Sustained release dosage form
|
FR2654337B1
(fr)
*
|
1989-11-15 |
1994-08-05 |
Roussel Uclaf |
Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.
|
US5126147A
(en)
*
|
1990-02-08 |
1992-06-30 |
Biosearch, Inc. |
Sustained release dosage form
|
DE4005415C2
(de)
*
|
1990-02-21 |
1996-04-11 |
Boehringer Ingelheim Kg |
Verfahren zum Herstellen von Polyestern auf der Basis von Hydroxycarbonsäuren
|
US5733566A
(en)
*
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
US5288496A
(en)
*
|
1990-05-15 |
1994-02-22 |
Stolle Research & Development Corporation |
Growth promoters for animals
|
US6353030B1
(en)
*
|
1990-08-01 |
2002-03-05 |
Novartis Ag |
Relating to organic compounds
|
MY108621A
(en)
*
|
1990-08-01 |
1996-10-31 |
Novartis Ag |
Polylactide preparation and purification
|
NZ240214A
(en)
|
1990-10-16 |
1993-02-25 |
Takeda Chemical Industries Ltd |
Polymer compositions comprising a polylactic acid and a copolymer of glycolic acid and a hydroxycarboxylic acid; use as carrier for prolonged release pharmaceutical compositions of water soluble drugs
|
IT1249045B
(it)
*
|
1991-02-21 |
1995-02-11 |
Himont Inc |
Processo per la sintesi allo stato solido di polimeri dell'acido lattico e prodotti cosi ottenuti
|
US5142023A
(en)
*
|
1992-01-24 |
1992-08-25 |
Cargill, Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US6326458B1
(en)
|
1992-01-24 |
2001-12-04 |
Cargill, Inc. |
Continuous process for the manufacture of lactide and lactide polymers
|
US6005067A
(en)
*
|
1992-01-24 |
1999-12-21 |
Cargill Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US5247058A
(en)
*
|
1992-01-24 |
1993-09-21 |
Cargill, Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US5247059A
(en)
*
|
1992-01-24 |
1993-09-21 |
Cargill, Incorporated |
Continuous process for the manufacture of a purified lactide from esters of lactic acid
|
US5258488A
(en)
*
|
1992-01-24 |
1993-11-02 |
Cargill, Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US5294469A
(en)
*
|
1992-06-17 |
1994-03-15 |
Mitsui Toatsu Chemicals, Incorporated |
Industrial woven fabric and composite sheet comprising same
|
US5758053A
(en)
*
|
1992-07-22 |
1998-05-26 |
Hitachi, Ltd. |
Fault handling and recovery for system having plural processors
|
US6005068A
(en)
*
|
1992-10-02 |
1999-12-21 |
Cargill Incorporated |
Melt-stable amorphous lactide polymer film and process for manufacture thereof
|
WO1994008078A1
(en)
*
|
1992-10-02 |
1994-04-14 |
Cargill, Incorporated |
A melt-stable lactide polymer fabric and process for manufacture thereof
|
ATE173520T1
(de)
*
|
1992-10-02 |
1998-12-15 |
Cargill Inc |
Papier mit einer beschichtung aus schmelzstabilem polymer und dessen verfahren zur herstellung
|
US5338822A
(en)
*
|
1992-10-02 |
1994-08-16 |
Cargill, Incorporated |
Melt-stable lactide polymer composition and process for manufacture thereof
|
US5643595A
(en)
*
|
1992-11-24 |
1997-07-01 |
Alkermes Controlled Therapeutics Inc. Ii |
Growth promoters for animals
|
TW333456B
(en)
*
|
1992-12-07 |
1998-06-11 |
Takeda Pharm Ind Co Ltd |
A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
JP3645906B2
(ja)
|
1993-11-19 |
2005-05-11 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
マイクロカプセル封入された3−ピペリジニル−置換1,2−ベンズイソオキサゾール類及び1,2−ベンズイソチアゾール類
|
EP0789045B1
(de)
*
|
1995-08-29 |
2001-01-10 |
Kyowa Hakko Kogyo Co., Ltd. |
Verfahren zur herstellung von polyhydroxycarbonsäure
|
SE505146C2
(sv)
*
|
1995-10-19 |
1997-06-30 |
Biogram Ab |
Partiklar för fördröjd frisättning
|
WO1997031049A1
(fr)
*
|
1996-02-23 |
1997-08-28 |
Kyowa Hakko Kogyo Co., Ltd. |
Procede d'elaboration d'acide polyhydroxycarboxylique
|
US5968895A
(en)
|
1996-12-11 |
1999-10-19 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US20070185032A1
(en)
*
|
1996-12-11 |
2007-08-09 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US6126919A
(en)
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
US6113947A
(en)
*
|
1997-06-13 |
2000-09-05 |
Genentech, Inc. |
Controlled release microencapsulated NGF formulation
|
US6663899B2
(en)
|
1997-06-13 |
2003-12-16 |
Genentech, Inc. |
Controlled release microencapsulated NGF formulation
|
US6733767B2
(en)
|
1998-03-19 |
2004-05-11 |
Merck & Co., Inc. |
Liquid polymeric compositions for controlled release of bioactive substances
|
US6217844B1
(en)
|
1998-04-27 |
2001-04-17 |
Praecis Pharmaceuticals, Inc. |
Methods for detecting lesions in dense breast tissue using LHRH antagonists
|
DE60019638T2
(de)
*
|
1999-12-10 |
2005-09-22 |
Equipolymers Gmbh |
Katalysatorsysteme für polykondensationsreaktionen
|
US6960626B2
(en)
*
|
2000-01-21 |
2005-11-01 |
Cyclics Corporation |
Intimate physical mixtures containing macrocyclic polyester oligomer and filler
|
DK1310517T4
(da)
*
|
2000-08-07 |
2011-01-17 |
Wako Pure Chem Ind Ltd |
Mælkesyrepolymer og fremgangsmåde til fremstilling af denne
|
US6362308B1
(en)
|
2000-08-10 |
2002-03-26 |
Alkermes Controlled Therapeutics Inc. Ii |
Acid end group poly(d,l-lactide-co-glycolide) copolymers high glycolide content
|
AU9051501A
(en)
*
|
2000-08-16 |
2002-02-25 |
Tyco Healthcare |
High consistency absorbable polymeric resin
|
US7750109B2
(en)
|
2000-09-01 |
2010-07-06 |
Cyclics Corporation |
Use of a residual oligomer recyclate in the production of macrocyclic polyester oligomer
|
US7767781B2
(en)
|
2000-09-01 |
2010-08-03 |
Cyclics Corporation |
Preparation of low-acid polyalkylene terephthalate and preparation of macrocyclic polyester oligomer therefrom
|
CA2451187C
(en)
*
|
2001-06-22 |
2012-08-14 |
Southern Biosystems, Inc. |
Zero-order prolonged release coaxial implants
|
CA2451767A1
(en)
|
2001-06-27 |
2003-01-09 |
Cyclics Corporation |
Isolation, formulation, and shaping of macrocyclic oligoesters
|
TWI332407B
(en)
*
|
2001-06-29 |
2010-11-01 |
Takeda Chemical Industries Ltd |
Controlled release composition and method of producting the same
|
TWI225416B
(en)
|
2001-06-29 |
2004-12-21 |
Takeda Chemical Industries Ltd |
Sustained-release composition and process for producing the same
|
JP2003192773A
(ja)
*
|
2001-12-26 |
2003-07-09 |
Mitsui Chemicals Inc |
生体吸収性ポリヒドロキシカルボン酸及びその製造法
|
US6849600B2
(en)
*
|
2002-03-25 |
2005-02-01 |
The Regents Of The University Of California, Berkeley |
Corticotropin-releasing hormone analogs
|
WO2004029129A1
(ja)
*
|
2002-09-24 |
2004-04-08 |
Asahi Kasei Chemicals Corporation |
グリコール酸共重合体及びその製造方法
|
EP1440992A1
(de)
*
|
2003-01-21 |
2004-07-28 |
Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) |
Katalysatorzusammensetzung für die (Co)polymerisation von Lactid und Glycolid
|
US20060193825A1
(en)
*
|
2003-04-29 |
2006-08-31 |
Praecis Phamaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US20050112087A1
(en)
*
|
2003-04-29 |
2005-05-26 |
Musso Gary F. |
Pharmaceutical formulations for sustained drug delivery
|
CA2533314C
(en)
|
2003-07-18 |
2013-07-09 |
Oakwood Laboratories, L.L.C. |
Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions
|
US20060210614A1
(en)
*
|
2003-12-26 |
2006-09-21 |
Nastech Pharmaceutical Company Inc. |
Method of treatment of a metabolic disease using intranasal administration of exendin peptide
|
US20060074025A1
(en)
*
|
2003-12-26 |
2006-04-06 |
Nastech Pharmaceutical Company Inc. |
Therapeutic formulations for transmucosal administration that increase glucagon-like peptide-1 bioavailability
|
US20080318837A1
(en)
*
|
2003-12-26 |
2008-12-25 |
Nastech Pharmaceutical Company Inc. |
Pharmaceutical Formation For Increased Epithelial Permeability of Glucose-Regulating Peptide
|
US20050143303A1
(en)
*
|
2003-12-26 |
2005-06-30 |
Nastech Pharmaceutical Company Inc. |
Intranasal administration of glucose-regulating peptides
|
WO2005105908A1
(ja)
*
|
2004-04-28 |
2005-11-10 |
Keio University |
主鎖にエステル結合を有するポリマーの解重合方法及び解重合生成物から主鎖にエステル結合を有するポリマーを製造する方法
|
CA2567331C
(en)
*
|
2004-05-21 |
2012-08-14 |
Microtherapeutics, Inc. |
Metallic coils enlaced with biological or biodegradable or synthetic polymers or fibers for embolization of a body cavity
|
US20070254314A1
(en)
*
|
2004-09-16 |
2007-11-01 |
Geier Mark R |
Methods of treating autism and autism spectrum disorders
|
ATE448737T1
(de)
|
2004-09-22 |
2009-12-15 |
Dendron Gmbh |
Vorrichtung zur implantation von mikrowendeln
|
DE102005019782A1
(de)
*
|
2005-04-28 |
2006-11-09 |
Dendron Gmbh |
Vorrichtung zur Implantation von Okklusionswendeln mit innenliegendem Sicherungsmittel
|
US7342048B2
(en)
*
|
2005-04-28 |
2008-03-11 |
Nipro Corporation |
Bioabsorbable pharmaceutical formulation
|
US8362086B2
(en)
|
2005-08-19 |
2013-01-29 |
Merial Limited |
Long acting injectable formulations
|
US8882747B2
(en)
*
|
2005-11-09 |
2014-11-11 |
The Invention Science Fund I, Llc |
Substance delivery system
|
RU2008124109A
(ru)
*
|
2005-12-08 |
2010-01-20 |
МДРНА, Инк. (US) |
Чресслизистая доставка стабилизированных композиций эксендина
|
DK2444807T3
(da)
|
2006-11-01 |
2014-08-11 |
Ventana Med Syst Inc |
Mono- og dinitropyrazolhaptenkonjugater
|
EA016176B1
(ru)
|
2006-12-18 |
2012-02-28 |
Такеда Фармасьютикал Компани Лимитед |
Композиция с замедленным высвобождением и способ её получения
|
ES2437619T3
(es)
|
2007-03-13 |
2014-01-13 |
Covidien Lp |
Un implante que incluye un arrollamiento helicoidal y un elemento resistente al estiramiento
|
US20100120811A1
(en)
|
2008-07-17 |
2010-05-13 |
Peter Hanson |
Long-acting injectable analgesic formulations for animals
|
AU2008363295B2
(en)
|
2008-10-20 |
2015-05-07 |
Forschungsverbund Berlin E.V. |
Low molecular weight thyroid stimulating hormone receptor (TSHR) agonists
|
US8653086B2
(en)
|
2008-10-21 |
2014-02-18 |
Oregon Health & Science University |
Naphthamides as anticancer agents
|
CN101445595B
(zh)
*
|
2008-12-26 |
2011-01-19 |
上海新上化高分子材料有限公司 |
聚乙丙交酯及其制备方法和应用
|
US9365612B2
(en)
|
2010-01-29 |
2016-06-14 |
United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Caspase inhibitors
|
EP2563777A4
(de)
|
2010-04-08 |
2013-09-04 |
Us Health |
Inverse agonisten und neutrale agonisten für den tsh-rezeptor
|
WO2012125486A1
(en)
|
2011-03-11 |
2012-09-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Combination chemotherapy for treating cancer
|
WO2012125787A1
(en)
|
2011-03-17 |
2012-09-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic |
METHODS FOR TREATING LEUKEMIA AND DISORDERS MEDIATED BY CBFβ AND RUNX1 PROTEINS
|
CN102295765B
(zh)
*
|
2011-06-30 |
2012-11-28 |
南京大学 |
生物质肌酐催化共缩聚法合成聚乳酸-乙醇酸
|
CN102329269B
(zh)
*
|
2011-06-30 |
2013-07-17 |
南京大学 |
仿生氯化肌酐胍催化缩聚法合成高分子量聚乳酸
|
WO2013039792A1
(en)
|
2011-09-12 |
2013-03-21 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Immunogens based on an hiv-1 gp120 v1v2 epitope
|
US20140234360A1
(en)
|
2011-09-30 |
2014-08-21 |
The United States of America, as represented by the Secretary, Dept.of Health and Human Services |
Influenza vaccine
|
EP2802565A4
(de)
|
2012-01-13 |
2015-07-08 |
Univ Oregon Health & Science |
Verbindungen, zusammensetzungen und zugehörige verfahren mit 3-aryl-chinolinen
|
CN104684895B
(zh)
|
2012-06-08 |
2017-09-15 |
高等教育联邦系统-匹兹堡大学 |
Fbxo3抑制剂
|
JP6272626B2
(ja)
|
2012-11-13 |
2018-01-31 |
ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
カンナビノイド受容体媒介性化合物
|
US9775895B2
(en)
|
2012-12-12 |
2017-10-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
HIV therapeutics and methods of making and using same
|
WO2014186398A1
(en)
|
2013-05-16 |
2014-11-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compounds for inhibiting drug-resistant strains of hiv-1 integrase
|
CA2924527C
(en)
|
2013-09-20 |
2022-07-12 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Compounds for treating prostate cancer
|
WO2015106003A1
(en)
|
2014-01-08 |
2015-07-16 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Ras pathways as markers of protection against hiv and methods to improve vaccine efficacy
|
CN106660968B
(zh)
|
2014-05-09 |
2020-02-07 |
美国政府(由卫生和人类服务部的部长所代表) |
吡唑衍生物及其作为大麻素受体介体的用途
|
EP3185868B1
(de)
|
2014-08-25 |
2022-04-06 |
Salk Institute for Biological Studies |
Neuartige ulk1-inhibitoren und verfahren zur verwendung davon
|
EP3189067B1
(de)
|
2014-09-04 |
2021-05-19 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Rekombinante hiv-1 hüllproteine und deren verwendung
|
WO2016064716A1
(en)
|
2014-10-20 |
2016-04-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Combination therapy of tshr antagonist and igfr inhibitor
|
WO2016103238A1
(en)
|
2014-12-24 |
2016-06-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant metapneumovirus f proteins and their use
|
WO2016112036A1
(en)
|
2015-01-05 |
2016-07-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Myc g-quadruplex stabilizing small molecules and their use
|
PE20180021A1
(es)
|
2015-02-20 |
2018-01-09 |
Univ Oregon Health & Science |
Derivados de sobetiroma
|
EP3303325A1
(de)
|
2015-06-04 |
2018-04-11 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Cannabinoid-rezeptorvermittelnde verbindungen
|
EP3347047A1
(de)
|
2015-09-09 |
2018-07-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Expressionsvektor-abgabesystem und dessen verwendung zur induzierung einer immunantwort
|
EP3423448A1
(de)
|
2016-03-04 |
2019-01-09 |
The U.S.A. as represented by the Secretary, Department of Health and Human Services |
Cannabinoid-rezeptorvermittelnde verbindungen
|
EP3936497A1
(de)
|
2016-05-18 |
2022-01-12 |
Oregon Health & Science University |
Verfahren zur herstellung von derivate von sobetirom
|
WO2017218963A1
(en)
|
2016-06-16 |
2017-12-21 |
Acies Bio D.O.O. |
Compositions and methods useful for treating diseases characterized by insufficient pantothenate kinase activity
|
EP3554538A2
(de)
|
2016-12-16 |
2019-10-23 |
Institute for Research in Biomedicine |
Neuartige rekombinante rsv-f-präfusionsproteine und verwendungen davon
|
EP3675921A1
(de)
|
2017-08-31 |
2020-07-08 |
Evonik Corporation |
Verbessertes reinigungsverfahren für resorbierbare polymere
|
WO2019118803A1
(en)
|
2017-12-14 |
2019-06-20 |
The United States Of America, As Represented By The Secretary,Department Of Health And Human Services |
Chemical entities for lytic activation of kshv and therapeutic targeting of viral enzymes/proteins
|
BR112020018832A2
(pt)
|
2018-03-29 |
2021-02-09 |
Elex Biotech, Inc. |
compostos para o tratamento de arritimias cardíacas e insuficiência cardíaca
|
CA3110224A1
(en)
|
2018-09-25 |
2020-04-02 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
2'-halogenated-4'-thio-2'-deoxy-5-azacytidine analogs and use thereof
|
AU2019397067A1
(en)
|
2018-12-12 |
2021-07-22 |
Autobahn Therapeutics, Inc. |
Novel thyromimetics
|
EP3931180A1
(de)
|
2019-03-01 |
2022-01-05 |
Autobahn Therapeutics, Inc. |
Neuartige thyromimetika
|
EP3937917B1
(de)
|
2019-03-11 |
2023-11-15 |
Oregon State University |
Analoga und derivate von cephalotaxin und verfahren zur herstellung und verwendung der verbindungen
|
AU2022288631A1
(en)
|
2021-06-09 |
2024-01-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compounds that bind non-canonical g-quadruplex structures and methods of making and using the same
|
WO2023059867A1
(en)
|
2021-10-08 |
2023-04-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compounds for treating or preventing alzheimer's disease
|
WO2023146771A1
(en)
|
2022-01-25 |
2023-08-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Gingerenone a prodrugs as senotherapeutics and methods of use
|
WO2023177568A1
(en)
|
2022-03-14 |
2023-09-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cannabinoid receptor modulating compounds
|